ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,599,402 | -51.0% | 126,862 | -52.5% | 0.01% | -63.2% |
Q2 2023 | $5,302,429 | +213.8% | 266,856 | +170.5% | 0.02% | +171.4% |
Q1 2023 | $1,689,857 | +123.5% | 98,649 | +79.6% | 0.01% | +16.7% |
Q2 2022 | $756,000 | +52.1% | 54,935 | +75.3% | 0.01% | +50.0% |
Q1 2022 | $497,000 | -19.6% | 31,345 | +10.7% | 0.00% | -20.0% |
Q4 2021 | $618,000 | +2.0% | 28,316 | +107.4% | 0.01% | -50.0% |
Q1 2021 | $606,000 | +146.3% | 13,650 | +26.1% | 0.01% | +25.0% |
Q4 2019 | $246,000 | – | 10,826 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |